Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

737 results about "Thoracic structure" patented technology

Structures within the thoracic cavity include: structures of the cardiovascular system, including the heart and great vessels, which include the thoracic aorta, the pulmonary artery and all its branches, the superior and inferior vena cava, the pulmonary veins, and the azygos vein

Intraluminal anastomotic device

An intestinal intraluminal reconstruction and resection device includes a mechanism for intussusception of the bowel, a bowel anastomosis mechanism and a mechanism for severing the resected bowel. The surgical device allows the user to carry out intraluminally an anastomosis first, prior to resection of the intestine or any hollow viscus, therefore not exposing the dirty intraluminal content to the clean abdominal or thoracic cavities. The above is achieved by first intussuscepting the hollow viscus, then anastomosis and finally intraluminal resection.
Owner:RAVO BIAGIO +1

Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis

A valve prosthesis for implantation in the body by use of a catheter includes a stent made from an expandable cylinder-shaped thread structure including several spaced apices. The elastically collapsible valve is mounted on the stent as the commissural points of the valve are secured to the projecting apices. The valve prosthesis can be compressed around balloons of the balloon catheter and inserted in a channel, for instance, in the aorta. When the valve prosthesis is placed correctly, the balloons are inflated to expand the stent and wedge it against the wall of the aorta. The balloons are provided with beads to ensure a steady fastening of the valve prosthesis on the balloons during insertion and expansion. The valve prosthesis and the balloon catheter make it possible to insert a cardiac valve prosthesis without a surgical operation involving opening the thoracic cavity.
Owner:EDWARDS LIFESCIENCES AG

Methods and systems for ultrasound imaging of the heart from the pericardium

A peritoneal ultrasound imager includes an elongated body less than about 20 inches in length that is adapted to be inserted through a cannula into or near the pericardium space, and an ultrasound transducer array at one end of the body that is suitable for ultrasound echocardiography. The cannula and ultrasound imager may be of a single piece construction. A method for imaging the heart includes introducing a cannula into the wall of a patient's chest, inserting the elongated body into the cannula, moving the inserted elongated body to a position near the heart, and imaging the heart with ultrasound echo.
Owner:EP MEDSYST

Apparatus and methods for facilitating treatment of tissue via improved delivery of energy based and non-energy based modalities

Methods and apparatus for accessing and treating regions of the body are disclosed herein. Using an endoscopic device having an automatically controllable proximal portion and a selectively steerable distal portion, the device generally may be advanced into the body through an opening. The distal portion is selectively steered to assume a selected curve along a desired path within the body which avoids contact with tissue while the proximal portion is automatically controlled to assume the selected curve of the distal portion. The endoscopic device can then be used for accessing various regions of the body which are typically difficult to access and treat through conventional surgical techniques because the device is unconstrained by “straight-line” requirements. Various applications can include accessing regions of the brain, thoracic cavity, including regions within the heart, peritoneal cavity, etc., which are difficult to reach using conventional surgical procedures.
Owner:INTUITIVE SURGICAL OPERATIONS INC

Lung device with sealing features

InactiveUS20060025815A1Reduce air leakageMitigates pneumothorax and hemothoraxSurgical needlesMedical devicesThoracic structureThoracic cavity
This invention relates generally to a design of lung devices for safely performing a transthoracic procedure. In particular, the invention provides devices and methods of using these devices to access the thoracic cavity with minimal risk of causing pneumothorax or hemothorax. More specifically, the invention enables diagnostic and therapeutic access to a thoracic cavity using large bore instruments. This invention also provides a method for diagnostic and therapeutic procedures using a device capable of sealing the wound upon withdrawal of the device. The invention includes a device comprising an elongated body adapted to make contact with a tissue of a subject through an access hole, and a sealant delivery element. The invention also includes a method of performing tissue treatment or diagnosis in a subject.
Owner:EKOS CORP

Method for cryospray ablation

The present invention relates to methods for treating tissue in the thoracic cavity of a subject by the application of a cryogen, or using the cryogen to create an isotherm in proximity to the tissue to be treated. A wide variety of conditions may be treated using the methods of the invention including asthma, neoplastic disease and a variety of conditions characterized by inflammation in lung and chest tissue.
Owner:RESET MEDICAL

Endoscopic system for treating inside of body cavity

There is provided an endoscopic inserting system. The system includes an endoscope which is inserted into a lumen inside a body through a natural opening of a human body, an opening member which forms an opening for inserting the endoscope into a thoracic cavity or an abdominal cavity from the lumen inside the body at a wall portion of the lumen, and a retracting member which, when forming the opening, retracts the wall portion of the lumen.
Owner:APOLLO ENDOSURGERY INC

Devices and methods for port-access multivessel coronary artery bypass surgery

Surgical methods and instruments are disclosed for performing port-access or closed-chest coronary artery bypass (CABG) surgery in multivessel coronary artery disease. In contrast to standard open-chest CABG surgery, which requires a median sternotomy or other gross thoracotomy to expose the patient's heart, post-access CABG surgery is performed through small incisions or access ports made through the intercostal spaces between the patient's ribs, resulting in greatly reduced pain and morbidity to the patient. In situ arterial bypass grafts, such as the internal mammary arteries and / or the right gastroepiploic artery, are prepared for grafting by thoracoscopic or laparoscopic takedown techniques. Free grafts, such as a saphenous vein graft or a free arterial graft, can be used to augment the in situ arterial grafts. The graft vessels are anastomosed to the coronary arteries under direct visualization through a cardioscopic microscope inserted through an intercostal access port. Retraction instruments are provided to manipulate the heart within the closed chest of the patient to expose each of the coronary arteries for visualization and anastomosis. Disclosed are a tunneler and an articulated tunneling grasper for rerouting the graft vessels, and a finger-like retractor, a suction cup retractor, a snare retractor and a loop retractor for manipulating the heart. Also disclosed is a port-access topical cooling device for improving myocardial protection during the port-access CABG procedure. An alternate surgical approach using an anterior mediastinotomy is also described.
Owner:HEARTPORT

Methods and apparatus for transesophageal microaccess surgery

The current invention describes methods of transesophageal access to the neck and thorax to perform surgical interventions on structures outside the esophagus in both the cervical and the thoracic cavity. It describes a liner device made of a complete or partial tubular structure, or a flat plate, the liner having means to facilitate creation of a side opening, which may include a valve. The liner with its side opening form a port structure inside the esophageal lumen. The port structure allows elongated surgical devices to pass through a perforation across the full thickness of the esophageal wall to outside location, in a controlled way. The elongated surgical devices can be diagnostic scopes, therapeutic scopes, manual elongated surgical devices, robotic arms or the like. After being deployed outside the esophagus, the surgical devices can access structures outside the esophagus, in the neck and thorax in 360 degrees of freedom around the esophageal circumference. These structures can be bony, cartilaginous, spinal, vascular, soft tissue, deep tissues, lymph nodal, cardiac, pulmonary, tracheal, nervous, muscular or diaphragmatic, skin and subcutaneous tissues of the neck, skin and subcutaneous tissues of the anterior chest wall, skin and subcutaneous tissues of the skin of the back, and skin and layers of the breast.
Owner:MICROACCESS

Endoscopic System and Method for Therapeutic Applications and Obtaining 3-Dimensional Human Vision Simulated Imaging With Real Dynamic Convergence

An endoscopic system and method that is adaptable for therapeutic applications as well as sensor operation and is capable of producing 3-dimensional human vision simulated imaging with real dynamic convergence, not virtual convergence. Applications may include use in any space, including but not limited to, intra-abdominal cavities, intra-thoracic cavities, and intra-cranial cavities. Further, two or more diagnostic / sensor probes may be used, with at least two being the same kind to create the 3-dimensional effect, such as but not limited to, camera, ultrasound, and magnetic-resonance imaging. Diagnostic / sensor probes are each mounted to the end of a different arm, with the other ends of the two arms both being attached to the same hinge that allows them to turn freely on the same axis from side-to-side within a 180 degree angle range of movement on the distal end of a main tubular shaft system. Medical, as well as other applications, are contemplated.
Owner:ABOU EL KHEIR TAREK AHMED NABIL

Subcutaneous cardioverter-defibrillator

SubQ ICDs are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion-defibrillation sense and stimulation electrodes for delivery of cardioversion-defibrillation shock and pacing therapies across the heart when necessary. Configurations include one hermetically sealed housing with 1 or, optionally, 2 subcutaneous sensing and cardioversion-defibrillation therapy delivery leads or alternatively, 2 hermetically sealed housings interconnected by a power / signal cable. The housings are generally dynamically configurable to adjust to varying rib structure and associated articulation of the thoracic cavity and muscles. Further the housings may optionally be flexibly adjusted for ease of implant and patient comfort.
Owner:MEDTRONIC INC

Methods and apparatus for accessing and treating regions of the body

Methods and apparatus for accessing and treating regions of the body are disclosed herein. Using an endoscopic device having an automatically controllable proximal portion and a selectively steerable distal portion, the device generally may be advanced into the body through an opening. The distal portion is selectively steered to assume a selected curve along a desired path within the body which avoids contact with tissue while the proximal portion is automatically controlled to assume the selected curve of the distal portion. The endoscopic device can then be used for accessing various regions of the body which are typically difficult to access and treat through conventional surgical techniques because the device is unconstrained by “straight-line” requirements. Various applications can include accessing regions of the brain, thoracic cavity, including regions within the heart, peritoneal cavity, etc., which are difficult to reach using conventional surgical procedures.
Owner:INTUITIVE SURGICAL

Synchronization system between aortic valve and cardiac assist device

A cardiac assist device synchronization system includes a cardiac assist device and an acoustic or accelerometer sensor that provides a signal input to the cardiac assist device indicative of aortic valve closure. The cardiac assist device is coupled to a mammalian aorta and includes an inflatable chamber and a fluid pump. A fluid conduit is in communication between the chamber and the pump to provide for selective inflation of the chamber. A pump controller triggers the pump in counter-pulsation to a mammalian heart upstream from the aorta. A process for synchronizing a cardiac assist device in counter-pulsation with a left ventricle includes locating an acoustic or accelerometer sensor within a thoracic cavity of a mammal having the assist device coupled to the aorta of the mammal. Through the measurement of an acoustic or acceleration property of an aortic valve of the mammal, and the transmission of aortic valve closure measurement through a controller for the cardiac assist device, counter-pulsatile synchronization for the cardiac assist device is achieved.
Owner:KANTROWITZ ALLEN B +1

Method and system for performing closed-chest bypass

A coronary artery bypass graft procedure is performed through one or more openings made in the patient to create a point of entry to the thoracic cavity. A vein measurement device measures the distance between the proximal and distal anastomotic sites for each graft. A proximal anastomosis tool splits to release a graft vessel after deploying an anastomosis device at the proximal anastomosis site. The tool may be articulated. An integrated stabilizer stabilizes one or more tools relative to the surface of the beating heart at a distal anastomotic site. A distal anastomotic tool may be provided as part of the integrated stabilizer, and connects one end of the graft vessel to a target vessel. An epicardial dissector may be provided as part of the integrated stabilizer, and dissects the epicardium from the target vessel at a distal anastomotic site, as needed.
Owner:AESCULAP AG

Devices and methods for intracardiac procedures

The invention provides devices and methods for performing less-invasive surgical procedures within an organ or vessel. In an exemplary embodiment, the invention provides a method of closed-chest surgical intervention within an internal cavity of a patient's heart or great vessel. According to the method, the patient's heart is arrested and cardiopulmonary bypass is established. A scope extending through a percutaneous intercostal penetration in the patient's chest is used to view an internal portion of the patient's chest. An internal penetration is formed in a wall of the heart or great vessel using cutting means introduced through a percutaneous penetration in an intercostal space in the patient's chest. An interventional tool is then introduced, usually through a cannula positioned in a percutaneous intercostal penetration. The interventional tool is inserted through the internal penetration in the heart or great vessel to perform a surgical procedure within the internal cavity under visualization by means of the scope. In a preferred embodiment, a cutting tool is introduced into the patient's left atrium from a right portion of the patient's chest to remove the patient's mitral valve. A replacement valve is then introduced through an intercostal space in the right portion of the chest and through the internal penetration in the heart, and the replacement valve is attached in the mitral valve position.
Owner:EDWARDS LIFESCIENCES LLC

Implantable myocardial ischemia detection, indication and action technology

InactiveUS7277745B2Reduce capacityReduce mechanical performance requirementsElectrocardiographyHeart defibrillatorsThoracic structureCardiac muscle
One embodiment enables detection of MI / I and emerging infarction in an implantable system. A plurality of devices may be used to gather and interpret data from within the heart, from the heart surface, and / or from the thoracic cavity. The apparatus may further alert the patient and / or communicate the condition to an external device or medical caregiver. Additionally, the implanted apparatus may initiate therapy of MI / I and emerging infarction.
Owner:INFINITE BIOMEDICAL TECH

Lung simulator

The present invention provides a lung simulator comprising a substantially-rigid, fluid-tight, translucent housing simulating a human thoracic cavity and at least one flexible air-tight bag simulating a lung having a plurality of simulated lung lobes, and a corresponding plurality of valves, each of the plurality of valves coupled to a one of the plurality of simulated lung lobes and configured to simulate varying degrees of fluid flow resistance. In a preferred embodiment, the substantially-rigid, fluid-tight, transparent housing has isolated simulated left and right thoracic cavities therein and the at least one flexible air-tight bag is located within one of the simulated thoracic cavities. The present invention further provides a method of manufacturing a lung simulator.
Owner:ESTETTER ROBERT H +2

Methods and Apparatus for Selectively Shunting Energy in an Implantable Extra-Cardiac Defibrillation Device

The disclosure provides methods and apparatus for simultaneously providing protection to an implantable medical device, such as an extra-cardiac implantable defibrillator (EID), while allowing efficacious therapy delivery via an external defibrillator (e.g., an automated external defibrillator, or AED). Due to the orientation of the electrodes upon application of therapy via, for example, via an AED the structure of the EID essentially blocks therapy delivery. In addition, but for the teaching of this disclosure sensitive circuitry of an EID can be damaged during application of external high voltage therapy thus rendering the EID inoperable. EIDs are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion-defibrillation sense and stimulation electrodes for delivery of cardioversion-defibrillation shock and pacing therapies across the heart when necessary. Configurations include one hermetically sealed housing with one or, optionally, two subcutaneous sensing and cardioversion-defibrillation therapy delivery leads or alternatively, two hermetically sealed housings interconnected by a power / signal cable. The housings are generally dynamically configurable to adjust to varying rib structure and associated articulation of the thoracic cavity and muscles. Further the housings may optionally be flexibly adjusted for ease of implant and patient comfort. One aspect includes partially insulating a surface of an EID that faces away from a heart while maintaining a major conductive surface facing the heart.
Owner:MEDTRONIC INC

Anti-coagulation and demineralization system for conductive medical devices

ActiveUS20060009804A1Prevention and elimination of blood component depositElectrotherapyArtificial respirationThoracic structureElectricity
A system for minimizing and / or eliminating coagulative or mineral deposits on respective blood-contacting surfaces of implanted medical devices includes an implantable system having a current generating device that is electrically coupled to at least first and second electrodes for developing a current therebetween. The at least first and second electrodes are disposed across a patient's thoracic cavity in a manner so that a particular implanted medical device having at least a portion thereof that is fabricated from an electrically conductive material is disposed in a path substantially between such electrodes, thereby focusing the generated electrical current at the electrically conductive portion of the implanted medical device for therapeutic treatment thereat.
Owner:MEDTRONIC PS MEDICAL

Subcutaneous cardioverter-defibrillator

SubQ ICDs are disclosed that are entirely implantable subcutaneously with minimal surgical intrusion into the body of the patient and provide distributed cardioversion-defibrillation sense and stimulation electrodes for delivery of cardioversion-defibrillation shock and pacing therapies across the heart when necessary. Configurations include one hermetically sealed housing with 1 or, optionally, 2 subcutaneous sensing and cardioversion-defibrillation therapy delivery leads or alternatively, 2 hermetically sealed housings interconnected by a power / signal cable. The housings are generally dynamically configurable to adjust to varying rib structure and associated articulation of the thoracic cavity and muscles. Further the housings may optionally be flexibly adjusted for ease of implant and patient comfort.
Owner:MEDTRONIC INC

Progressive biventricular diastolic support device

A device is proposed to progressively reduce the hemodynamic cardiac symptoms of congestive heart failure as well as those induced by dilated cardiomyopathies. This device affords progressive diastolic ventricular control by offering a method for percutaneous access and adjustments of its gas filled bladders surrounding the heart. After opening the pericardium, the device is not attached to the heart muscle but may be anchored to the pericardial sac. The device actually extends primarily around the heart from below the atrio-ventricular canal to the cardiac apex. Between the device exterior, made of non-elastic material and the epicardium, two independent elastic bladders or chambers provide variable compressive diastolic support to the right and left ventricles, while allowing adequate blood flow to the anterior and posterior descending epicardial branches of the coronary arteries and veins. Progressive hemodynamic increases in diastolic pressures for the right and left ventricles can be individually and repeatedly monitored by pressure gauges and an inert gas separately injected or removed in the enclosed chest through self-sealing access ports. These ports are subcutaneously implanted in the left anterior axillary line and connected by thin tubes across the 4th or 5th intercostal spaces to the pericardial bladders or chambers described above.
Owner:ROBERTSON JR ABEL L

Pulmonary Monitoring System

A method of monitoring pulmonary oedema in a subject using a processing system. The method includes, determining a measured impedance value for at least two body segments, at least one of the body segments being a thoracic cavity segment. For each body segment, the measured impedance values are used to determine an index, which is in turn used to determine the presence, absence or degree of pulmonary oedema using the determined indices.
Owner:IMPEDANCE CARDIOLOGY SYST +1

Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease

A single-phase surgical procedure is disclosed for creating a pneumostoma to treat chronic obstructive pulmonary disease. In a single-phase technique the pleurodesis is formed at the same time as the pneumostoma and does not require a separate step. The thoracic cavity is accessed to visualize the lung, the pneumostomy catheter is inserted into the lung and then the lung is secured to the channel through the chest wall creating a sealed anastomosis which matures into a pleurodesis after the procedure.
Owner:PORTAERO

Method and apparatus for chest drainage

The present invention describes a device for placement in the thoracic cavity of a patient. The device is a cannula, tube or catheter for chest drainage. The device serves as a conduit for drainage of excessive fluid or air buildup in the chest to a receptacle outside the body. The device also serves to prevent influx of fluid or air into the chest cavity, thus preventing pneumothorax or infection. The device incorporates systems for anchoring the chest drainage cannula to the chest and for steering the chest drainage cannula into the thoracic cavity.
Owner:BREZNOCK EUGENE M +1

Method and apparatus for chest drainage

InactiveUS7326197B2Minimizing chanceReducing chance of iatrogenic injuryInfusion syringesWound drainsThoracic structurePneumothorax
The present invention describes a device for placement in the thoracic cavity of a patient. The device is a cannula, tube or catheter for chest drainage. The device serves as a conduit for drainage of excessive fluid or air buildup in the chest to a receptacle outside the body. The device also serves to prevent influx of fluid or air into the chest cavity, thus preventing pneumothorax or infection. The device incorporates systems for anchoring the chest drainage cannula to the chest and for steering the chest drainage cannula into the thoracic cavity.
Owner:BREZNOCK EUGENE M +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products